NO20054885L - 3-alkylidenhydrazino substituerte heteroarylforbindelser som trombopoietin reseptor aktivator - Google Patents

3-alkylidenhydrazino substituerte heteroarylforbindelser som trombopoietin reseptor aktivator

Info

Publication number
NO20054885L
NO20054885L NO20054885A NO20054885A NO20054885L NO 20054885 L NO20054885 L NO 20054885L NO 20054885 A NO20054885 A NO 20054885A NO 20054885 A NO20054885 A NO 20054885A NO 20054885 L NO20054885 L NO 20054885L
Authority
NO
Norway
Prior art keywords
atom
substituted heteroaryl
receptor activator
heteroaryl compounds
thrombopoietin receptor
Prior art date
Application number
NO20054885A
Other languages
English (en)
Other versions
NO20054885D0 (no
NO334084B1 (no
Inventor
Takanori Nakamura
Kazufumi Yanagihara
Norihisa Ishiwata
Shingo Owada
Shunsuke Iwamoto
Katsuaki Miyaji
Yutaka Hirokawa
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Publication of NO20054885D0 publication Critical patent/NO20054885D0/no
Publication of NO20054885L publication Critical patent/NO20054885L/no
Publication of NO334084B1 publication Critical patent/NO334084B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/32—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Forbindelse representert ved formelen (1): hvor A er et nitrogenatom eller CR4, B er et oksygenatom, et svovelatom eller NR9 (forutsatt at når A er et nitrogenatom, B er ikke NH) , R1 er en C2-i4 arylgruppe, L1 er en binding, CR10R11, et oksygenatom, et svovelatom eller NR12, X er OR13, SR13 eller NR14NR15, R2 er et hydrogenatom, en formylgruppe, en Ci-m alkylgruppe eller lignende, L2 er en binding eller lignende, L3 er en binding, CR17R18, et oksygenatom, et svovelatom eller NR19, L4 er en binding, CR20R21, et oksygenatom, et svovelatom eller NR22, Y er et oksygenatom, et svovelatom eller NR23 og R3 er en C2-i4 arylgruppe, en tautomer, prodroge eller farmasøytisk akseptabelt salt av forbindelsen eller et solvat derav.
NO20054885A 2003-06-06 2005-10-21 3-alkylidenhydrazino substituerte heteroarylforbindelser, medikamenter omfattende slike forbindelser, slike forbindelser som medikamenter og slike forbindelser som blodplateøkende middel NO334084B1 (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2003161987 2003-06-06
JP2003330627 2003-09-22
JP2003404635 2003-12-03
JP2004094931 2004-03-29
PCT/JP2004/008165 WO2004108683A1 (en) 2003-06-06 2004-06-04 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators

Publications (3)

Publication Number Publication Date
NO20054885D0 NO20054885D0 (no) 2005-10-21
NO20054885L true NO20054885L (no) 2005-12-28
NO334084B1 NO334084B1 (no) 2013-12-09

Family

ID=33514809

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054885A NO334084B1 (no) 2003-06-06 2005-10-21 3-alkylidenhydrazino substituerte heteroarylforbindelser, medikamenter omfattende slike forbindelser, slike forbindelser som medikamenter og slike forbindelser som blodplateøkende middel

Country Status (17)

Country Link
US (5) US7351841B2 (no)
EP (1) EP1636192B9 (no)
JP (2) JP4386072B2 (no)
KR (1) KR101211975B1 (no)
AU (1) AU2004245401B2 (no)
CA (1) CA2520115C (no)
DK (1) DK1636192T3 (no)
ES (1) ES2445029T3 (no)
IL (1) IL172374A (no)
MX (1) MXPA05013209A (no)
NO (1) NO334084B1 (no)
NZ (1) NZ542495A (no)
PL (1) PL1636192T3 (no)
PT (1) PT1636192E (no)
TW (1) TWI395739B (no)
UA (1) UA82695C2 (no)
WO (1) WO2004108683A1 (no)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA82695C2 (uk) 2003-06-06 2008-05-12 Нисан Кемикал Индастриз, Лтд. Гетероароматичні сполуки як активатори рецептора тромбопоетину
FR2866886B1 (fr) * 2004-02-26 2007-08-31 Sanofi Synthelabo Derives d'aryl-et d'heteroaryl-akylcarbamates, leur preparation et leur application en therapeutique
WO2005118551A2 (en) * 2004-05-28 2005-12-15 Ligand Pharmaceuticals Inc. Thrombopoietin activity modulating compounds and methods
CA2583764C (en) * 2004-10-25 2009-06-09 Ligand Pharmaceuticals, Inc. Thrombopoietin activity modulating compounds and methods
CA2588979C (en) * 2004-12-08 2013-01-22 Nissan Chemical Industries, Ltd. 3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators
CN101072766B (zh) * 2004-12-08 2012-05-02 日产化学工业株式会社 作为血小板生成素受体激活剂的3-亚乙基肼基取代的杂环化合物
TW200633998A (en) * 2004-12-08 2006-10-01 Nissan Chemical Ind Ltd Substituted heterocyclic compounds and thrombopoietin receptor activators
TW200633997A (en) * 2004-12-08 2006-10-01 Nissan Chemical Ind Ltd Substituted heterocyclic compounds and thrombopoietin receptor activators
US8134013B2 (en) 2004-12-14 2012-03-13 Nissan Chemical Industries, Ltd. Amide compound and thrombopoietin receptor activator
WO2007010954A1 (en) * 2005-07-15 2007-01-25 Nissan Chemical Industries, Ltd. Thiophene compounds and thrombopoietin receptor activators
RU2424238C2 (ru) * 2005-07-15 2011-07-20 Ниссан Кемикал Индастриз, Лтд. Тиофеновые соединения и активаторы рецептора тромбопоэтина
KR101290484B1 (ko) 2005-07-20 2013-07-26 닛산 가가쿠 고교 가부시키 가이샤 피라졸 화합물 및 트롬보포이에틴 수용체 활성화제
JP5205967B2 (ja) * 2005-11-07 2013-06-05 日産化学工業株式会社 ヒドラジド化合物及びトロンボポエチンレセプター活性化剤
JP5157900B2 (ja) * 2006-06-07 2013-03-06 日産化学工業株式会社 含窒素ヘテロ環化合物及びトロンボポエチンレセプター活性化剤
US7784330B2 (en) * 2007-10-05 2010-08-31 Schlumberger Technology Corporation Viscosity measurement
WO2009072625A1 (ja) * 2007-12-05 2009-06-11 Nissan Chemical Industries, Ltd. ヘテロ環化合物による造血幹細胞の増幅方法
KR101585276B1 (ko) * 2007-12-05 2016-01-13 닛산 가가쿠 고교 가부시키 가이샤 헤테로 고리 화합물에 의한 조혈 줄기 세포의 증폭 방법
JP5573159B2 (ja) * 2007-12-05 2014-08-20 日産化学工業株式会社 ヘテロ環化合物による造血幹細胞の増幅方法
CN101889007A (zh) * 2007-12-06 2010-11-17 日产化学工业株式会社 采用杂环化合物的造血干细胞的扩增方法
HUE027833T2 (en) 2008-02-29 2016-11-28 Nissan Chemical Ind Ltd Process for the preparation of a thiophene derivative and its intermediate
JP2012521359A (ja) * 2009-03-20 2012-09-13 アリオス バイオファーマ インク． 置換されたヌクレオシドアナログおよびヌクレオチドアナログ
US8680150B2 (en) * 2009-05-28 2014-03-25 Ligand Pharmaceuticals, Inc. Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors
WO2010140685A1 (ja) 2009-06-04 2010-12-09 日産化学工業株式会社 ヘテロ環化合物及び造血幹細胞の増幅剤
WO2011049213A1 (ja) * 2009-10-23 2011-04-28 日産化学工業株式会社 縮環へテロ環化合物及びトロンボポエチンレセプター活性化剤
NZ607996A (en) 2010-09-22 2014-07-25 Alios Biopharma Inc Substituted nucleotide analogs
UA109287C2 (uk) * 2010-11-02 2015-08-10 Солі органічного аміну похідних амінобензойної кислоти і спосіб їх одержання
JP2012111750A (ja) * 2010-11-02 2012-06-14 Nissan Chem Ind Ltd アミノ安息香酸誘導体の溶媒和物及びその製造方法
KR102031386B1 (ko) 2011-10-03 2019-10-11 닛산 가가쿠 가부시키가이샤 다능성 간세포로부터의 거핵구 및/또는 혈소판의 제조 방법
CA2860234A1 (en) 2011-12-22 2013-06-27 Alios Biopharma, Inc. Substituted phosphorothioate nucleotide analogs
HK1206362A1 (zh) 2012-03-21 2016-01-08 Alios Biopharma, Inc. 硫代氨基磷酸酯核苷酸前藥的固體形式
WO2013142157A1 (en) 2012-03-22 2013-09-26 Alios Biopharma, Inc. Pharmaceutical combinations comprising a thionucleotide analog
CN103664622B (zh) * 2012-09-18 2016-01-13 浙江工业大学 Ab型羟基改性高聚物的单体及其中间体和制备方法
JP6279430B2 (ja) * 2014-08-21 2018-02-14 東芝メモリ株式会社 テンプレート、テンプレート形成方法および半導体装置の製造方法
JP6658535B2 (ja) 2014-10-31 2020-03-04 日産化学株式会社 リガンド結合繊維及び当該繊維を用いた細胞培養基材
WO2018199797A1 (ru) * 2017-04-27 2018-11-01 Общество с ограниченной ответственностью "ОнкоТартис" Замещенные 2-метилиден-5-(фениламино)-2,3-дигидротиофен-3-оны для лечения лейкозов с транслокациями mll-гена и других онкологических заболеваний
US20220267281A1 (en) * 2019-06-12 2022-08-25 Ontario Institute For Cancer Research (Oicr) Unsaturated heterocycloalkyl and heteroaromatic acyl hydrazone linkers, methods and uses thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0258182A1 (en) * 1986-08-08 1988-03-02 Sandoz Ag Semicarbazones and thiosemicarbazones
ZA981934B (en) * 1997-03-10 1999-09-06 Rhone Poulenc Agrochimie Pesticidal 1-aryl-3-iminopyrazoles.
US6270345B1 (en) * 1999-10-28 2001-08-07 Dove Systems, Inc. Vane motor for dental and medical handpieces
EP1228051A1 (en) 1999-11-05 2002-08-07 SmithKline Beecham Corporation Semicarbazone derivatives and their use as thrombopoietin mimetics
US6720345B1 (en) 1999-11-05 2004-04-13 Smithkline Beecham Corporation Semicarbazone derivatives and their use as thrombopoietin mimetics
JP2004520302A (ja) * 2000-12-19 2004-07-08 スミスクライン・ビーチャム・コーポレイション トロンボポエチン模倣物
EP1370252A4 (en) * 2001-03-01 2006-04-05 Smithkline Beecham Corp Thrombopoietin mimetics
EP1552828A4 (en) 2002-08-14 2007-01-24 Nissan Chemical Ind Ltd THROMBOPOIETIN RECEPTOR ACTIVATOR AND METHOD OF PRODUCTION
TWI324593B (en) 2002-10-09 2010-05-11 Nissan Chemical Ind Ltd Pyrazolone compounds and thrombopoietin receptor activator
UA82695C2 (uk) 2003-06-06 2008-05-12 Нисан Кемикал Индастриз, Лтд. Гетероароматичні сполуки як активатори рецептора тромбопоетину
CA2588979C (en) * 2004-12-08 2013-01-22 Nissan Chemical Industries, Ltd. 3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators
US8134013B2 (en) 2004-12-14 2012-03-13 Nissan Chemical Industries, Ltd. Amide compound and thrombopoietin receptor activator
JP4941301B2 (ja) 2005-04-14 2012-05-30 日産化学工業株式会社 α置換ビニルスズ化合物
WO2007010954A1 (en) 2005-07-15 2007-01-25 Nissan Chemical Industries, Ltd. Thiophene compounds and thrombopoietin receptor activators
KR101290484B1 (ko) 2005-07-20 2013-07-26 닛산 가가쿠 고교 가부시키 가이샤 피라졸 화합물 및 트롬보포이에틴 수용체 활성화제
JP5157900B2 (ja) 2006-06-07 2013-03-06 日産化学工業株式会社 含窒素ヘテロ環化合物及びトロンボポエチンレセプター活性化剤
JP5065974B2 (ja) * 2008-04-10 2012-11-07 株式会社船井電機新応用技術研究所 マイクロホンユニット及びその製造方法

Also Published As

Publication number Publication date
US20130012708A1 (en) 2013-01-10
AU2004245401B2 (en) 2009-11-12
US8318796B2 (en) 2012-11-27
CA2520115A1 (en) 2004-12-16
US20060094694A1 (en) 2006-05-04
EP1636192A1 (en) 2006-03-22
EP1636192B9 (en) 2015-07-01
IL172374A (en) 2014-08-31
NZ542495A (en) 2009-01-31
TW200510326A (en) 2005-03-16
KR20060015729A (ko) 2006-02-20
NO20054885D0 (no) 2005-10-21
UA82695C2 (uk) 2008-05-12
JP2010006821A (ja) 2010-01-14
HK1091809A1 (en) 2007-01-26
CA2520115C (en) 2012-10-02
AU2004245401A1 (en) 2004-12-16
US20080027068A1 (en) 2008-01-31
EP1636192B1 (en) 2014-01-15
US7351841B2 (en) 2008-04-01
US7576115B2 (en) 2009-08-18
ES2445029T3 (es) 2014-02-27
DK1636192T3 (en) 2014-03-03
JP4386072B2 (ja) 2009-12-16
TWI395739B (zh) 2013-05-11
US20140051857A1 (en) 2014-02-20
PL1636192T3 (pl) 2014-05-30
US20110077290A1 (en) 2011-03-31
PT1636192E (pt) 2014-02-11
KR101211975B1 (ko) 2012-12-13
JP5099089B2 (ja) 2012-12-12
NO334084B1 (no) 2013-12-09
JP2006527187A (ja) 2006-11-30
WO2004108683A1 (en) 2004-12-16
MXPA05013209A (es) 2006-03-09

Similar Documents

Publication Publication Date Title
NO20054885L (no) 3-alkylidenhydrazino substituerte heteroarylforbindelser som trombopoietin reseptor aktivator
TW200510381A (en) Novel 2-pyridinecarboxamide derivatives
EP1471065A4 (en) NEW 1,2,4-TRIAZONE COMPOUND
NO20054425L (no) Heteroarylkarbamoylbenzenderivater
DE60214591D1 (en) Pyrazolpyrimidinfungizide
NO20062633L (no) Pyrazolderivater som proteinkinasemodulatorer
TN2010000091A1 (en) Substituted pyrazole derivative
DK1414302T3 (da) 7-aminotriazolopyrimidiner til bekæmpelse af skadelige svampe
WO2003016291A1 (en) ACTIVATOR FOR PEROXISOME PROLIFERATOR-RESPONSIVE RECEPTOR δ
CY1113782T1 (el) Παραγωγα 11-υδροξυ-5η-πυρρολο[2,1-c][1,4]βενζοδιαζεπιν-5-ονης ως ενδιαμεσα κλειδια για την παρασκευη c2 υποκατεστημενων πυρρολοβενζοδιαζεπινων
GB0113233D0 (en) Chemical compounds
NO20081551L (no) Heterocyklisk substituerte pyridinderivater og antisoppmidler inneholdende samme
WO2008126889A1 (ja) ヒドラジド化合物及びそれを含有する有害節足動物防除剤
NO20051270L (no) Sammensmeltet benzenderivat og anvendelse
TW200738667A (en) Preparation method for dioxan-2-ylalkylcarbamate derivatives and intermediate thereof
TW376385B (en) Watersoluble azole antifungals
DE69509452D1 (de) Tetrazolinon-Herbizide
NO20072753L (no) 3-Etylidenhydrazinosubstituerte heterocykliske forbindelser som trombopoietinreseptoraktivatorer
NO20060426L (no) Kannabinoid reseptormodulator
EP1422219A4 (en) CYCLIC AMINE COMPOUND
EP1741714A4 (en) HETEROCYLIC COMPOUND AND ANTI-MALIGNANT TUMOR AGENT CONTAINING THE SAME AS ACTIVE INGREDIENT
WO2004046151A3 (en) Porphyrin derivatives
NO20073213L (no) Fremgangsmate for fremstilling av tiofenglykosidderivater
MXPA04000371A (es) 6- (2-tolil) - triazolopirimidinas substituidas.
WO2003049541A3 (en) Nematicidal trifluorobutenyl imidazole thioether derivatives

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees